Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk

Pharmacogenetics and Genomics

Volumn 20, Issue 5, 2010, Pages 315-326

  Northwood, Emma L ^a,b   Elliott, Faye ^a,b   Forman, David ^a,b   Barrett, Jennifer H ^a   Wilkie, Murray J V ^c   Carey, Francis A ^d   Steele, Robert J C ^d   Wolf, Roland ^e   Bishop, Timothy ^a,b   Smith, Gillian ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Faculty of Medicine and Health   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d University of Dundee ^*  (United States)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Colorectal adenoma; Diet; Gene environment interactions; Pharmacogenetics; Polymorphism; Xenobiotic metabolizing enzymes

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 2C9; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); XENOBIOTIC AGENT;

ADULT; ARTICLE; CANCER RISK; COLORECTAL ADENOMA; CONTROLLED STUDY; DIET; DNA POLYMORPHISM; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VEGETABLE;

EID: 77951499044     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283395c6a     Document Type: Article

References (72)

1. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev 1994; 16:273-297.
2. Giacosa A, Frascio F, Munizzi F. Epidemiology of colorectal polyps. Tech Coloproctol 2004; 8 (Suppl 2):s243-s247. (Pubitemid 40202478)
3. Fung T, Hu FB, Fuchs C, Giovannucci E, Hunter DJ, Stampfer MJ, et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 2003; 163:309-314. (Pubitemid 36183859)
4. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. Jama 2007; 298:754-764. (Pubitemid 47263158)
5. Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, Willett WC, et al. Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Res 2006; 66:3942-3953.
6. Platz EA, Giovannucci E, Rimm EB, Rockett HR, Stampfer MJ, Colditz GA, et al. Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev 1997; 6:661-670. (Pubitemid 27427620)
7. Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps. Am J Epidemiol 1996; 144:1015-1025.
8. Ferrucci LM, Sinha R, Graubard BI, Mayne ST, Ma X, Schatzkin A, et al. Dietary meat intake in relation to colorectal adenoma in asymptomatic women. Am J Gastroenterol 2009; 104:1231-1240.
9. Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, et al. Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:2421-2430.
10. Holst B, Williamson G. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep 2004; 21:425-447. (Pubitemid 38865722)
11. Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998; 7:647-652.
12. Wu H, Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Smalley WE, et al. Fruit and vegetable intakes are associated with lower risk of colorectal adenomas. J Nutr 2009; 139:340-344.
13. Shin A, Shrubsole MJ, Rice JM, Cai Q, Doll MA, Long J, et al. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 2008; 17:320-329. (Pubitemid 351272782)
14. Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, et al. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 2005; 65:8034-8041. (Pubitemid 41297285)
15. Bingham SA, Hughes R, Cross AJ. Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. J Nutr 2002; 132:3522S-3525S. (Pubitemid 35315831)
16. Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003; 63:2358-2360.
17. Nagao M, Sugimura T. Carcinogenic factors in food with relevance to colon cancer development. Mutat Res 1993; 290:43-51. (Pubitemid 23319755)
18. Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000; 21:387-395. (Pubitemid 30137924)
19. Lanza E, Yu B, Murphy G, Albert PS, Caan B, Marshall JR, et al. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and-vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol Biomarkers Prev 2007; 16:1745-1752. (Pubitemid 47450503)
20. Tiemersma EW, Voskuil DW, Bunschoten A, Hogendoorn EA, Witteman BJ, Nagengast FM, et al. Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004; 15:225-236. (Pubitemid 38988031)
21. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007; 16:2697-2703. (Pubitemid 351196326)
22. Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control 2009 [Epub ahead of print]
23. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res 2009; 670:6-14.
24. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991; 4:391-407.
25. Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005; 14:152-157. (Pubitemid 40165296)
26. Inoue H, Kiyohara C, Marugame T, Shinomiya S, Tsuji E, Handa K, et al. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res 2000; 60:3749-3752. (Pubitemid 32204563)
27. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 2001; 16:631-635. (Pubitemid 34188837)
28. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 1994; 3:675-682. (Pubitemid 24377961)
29. Haining RL, Hunter AP, Veronese ME, Trager WF, Rettie AE. Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys 1996; 333:447-458.
30. Takahashi H, Kashima T, Nomoto S, Iwade K, Tainaka H, Shimizu T, et al. Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes. Pharmacogenetics 1998; 8:365-373. (Pubitemid 28475300)
31. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005; 5:6-13. (Pubitemid 40220611)
32. Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006; 7:613-628. (Pubitemid 44226589)
33. Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, et al. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005; 14:1823-1827. (Pubitemid 40995101)
34. Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, et al. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 2006; 7:819-829. (Pubitemid 44446733)
35. Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005; 26:1122-1128. (Pubitemid 41214306)
36. Turner F, Smith G, Sachse C, Lightfoot T, Garner RC, Wolf CR, et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 2004; 112:259-264. (Pubitemid 39244365)
37. Barrett JH, Smith G, Waxman R, Gooderham N, Lightfoot T, Garner RC, et al. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 2003; 24:275-282. (Pubitemid 36267097)
38. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002; 23:1839-1849. (Pubitemid 35363272)
39. Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl 1):S26-S36.
40. Calvert C, Cade J, Barrett JH, Woodhouse A, UKWCS Steering Group. United Kingdom Women's Cohort Study Steering Group. Using crosscheck questions to address the problem of mis-reporting of specific food groups on Food Frequency Questionnaires. Eur J Clin Nutr 1997; 51:708-712.
41. Bresalier RS. Chemoprevention of colorectal cancer: why all the confusion? Curr Opin Gastroenterol 2008; 24:48-50. (Pubitemid 350190897)
42. Martinez ME, Marshall JR, Giovannucci E. Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer 2008; 8:694-703.
43. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14:1821-1824. (Pubitemid 23290894)
44. Bigler J, Whitton J, Lampe JW, Fosdick L, Bostick RM, Potter JD. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 2001; 61:3566-3569. (Pubitemid 32694961)
45. Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS. A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma. Clin Gastroenterol Hepatol 2004; 2:704-712.
46. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge M, Armitage N, et al. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res 2006; 12:6585-6589. (Pubitemid 44799734)
47. Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, et al. Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 2009; 136:2127-2136. e2121.
48. Lee CR. CYP2C9 genotype as a predictor of drug disposition in humans. Methods Find Exp Clin Pharmacol 2004; 26:463-472.
49. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol Carcinog 1994; 10:159-168. (Pubitemid 24257511)
50. Zhou SF, Zhou ZW, Yang LP, Cai JP. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem 2009; 16:3480-3675.
51. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005; 15:535-546. (Pubitemid 41044239)
52. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 2005; 574:112-123. (Pubitemid 40725973)
53. Topic E, Stefanovic M, Ivanisevic AM, Petrinovic R, Curcic I. The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients. Clin Chim Acta 2000; 296:101-109. (Pubitemid 30243143)
54. Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JC, Pass HI, et al. Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7:215-219. (Pubitemid 28353931)
55. Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 2005; 156:68-73. (Pubitemid 39601062)
56. Chen C, Cook LS, Li XY, Hallagan S, Madeleine MM, Daling JR, et al. CYP2D6 genotype and the incidence of anal and vulvar cancer. Cancer Epidemiol Biomarkers Prev 1999; 8:317-321. (Pubitemid 29193903)
57. Wark PA, Grubben MJ, Peters WH, Nagengast FM, Kampman E, Kok FJ, et al. Habitual consumption of fruits and vegetables: associations with human rectal glutathione S-transferase. Carcinogenesis 2004; 25:2135-2142. (Pubitemid 39534850)
58. Inoue H, Kiyohara C, Shinomiya S, Marugame T, Tsuji E, Handa K, et al. Glutathione S-transferase polymorphisms and risk of colorectal adenomas. Cancer Lett 2001; 163:201-206. (Pubitemid 32126366)
59. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Kriek E, Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002; 23:1969-1977. (Pubitemid 36104950)
60. Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk. Am J Clin Nutr 2009; 89:1553S-1557S.
61. Gunter MJ, Watson MA, Loktionov AS, Mitrou P, Cecil T, Macklin C, et al. No association between cytochrome P450 and glutathione S-transferase gene polymorphisms and risk of colorectal adenoma: results from the UK Flexible Sigmoidoscopy Screening Trial. Cancer Epidemiol Biomarkers Prev 2005; 14:1028-1030. (Pubitemid 40478580)
62. Tijhuis MJ, Wark PA, Aarts JM, Visker MH, Nagengast FM, Kok FJ, et al. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005; 14:2943-2951.
63. Lin HJ, Probst-Hensch NM, Ingles SA, Han CY, Lin BK, Lee DB, et al. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 1995; 55:1224-1226.
64. Hofmann T, Liegibel U, Winterhalter P, Bub A, Rechkemmer G, Pool-Zobel BL. Intervention with polyphenol-rich fruit juices results in an elevation of glutathione S-transferase P1 (hGSTP1) protein expression in human leucocytes of healthy volunteers. Mol Nutr Food Res 2006; 50:1191-1200. (Pubitemid 46032205)
65. Srivastava A, Akoh CC, Fischer J, Krewer G. Effect of anthocyanin fractions from selected cultivars of Georgia-grown blueberries on apoptosis and phase II enzymes. J Agric Food Chem 2007; 55:3180-3185. (Pubitemid 46668332)
66. Tijhuis MJ, Visker MH, Aarts JM, Peters WH, Roelofs HM, den Camp LO, et al. Glutathione S-transferase phenotypes in relation to genetic variation and fruit and vegetable consumption in an endoscopy-based population. Carcinogenesis 2007; 28:848-857.
67. Voskuil DW, Kampman E, Grubben MJ, Kok FJ, Nagengast FM, Vasen HF, et al. Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. Eur J Cancer 2002; 38:2300-2308. (Pubitemid 35346472)
68. Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005; 14:2030-2034. (Pubitemid 41161219)
69. Bassett ML, Goulston KJ. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction. Aust N Z J Med 1980; 10:1-4.
70. Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, et al. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001; 61:2381-2385. (Pubitemid 32685809)
71. Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, et al. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14:1350-1352. (Pubitemid 40656497)
72. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 2004; 25:1211-1218. (Pubitemid 38968049)